Administration Rate of Platelet Concentrates

Proper Administration Guidelines

Platelet concentrate should be stored at 22°C with constant gentle agitation in an approved incubator until ready for use 1, 4
Transfusion should ideally be commenced within 30 minutes of removal from the platelet storage incubator 1, 3
A standard adult therapeutic dose should be administered through a dedicated administration set with an appropriate filter 1, 2
Do not give platelets through a set that has already been used for red cells 1, 3
No drugs should be added directly to the unit of platelets 1, 3

Rapid infusion may increase the risk of adverse reactions, including transfusion-related acute lung injury (TRALI) and circulatory overload 5
Controlled infusion allows for better monitoring of potential transfusion reactions 4
The standard 30-minute infusion time has been established as the optimal balance between timely administration and preservation of platelet function 1, 3

Prevention and treatment of bleeding due to thrombocytopenia or platelet function defects 1, 4
For actively bleeding patients, transfuse to maintain a platelet count > 75 × 10^9/L 1, 4
For patients with traumatic brain injury or severe bleeding, a higher threshold of 100 × 10^9/L is recommended 5, 6
For non-bleeding patients with chemotherapy-induced thrombocytopenia, transfuse only if platelet count < 10 × 10^9/L 1, 4

Each standard adult therapeutic dose contains 250-350 ml with a platelet count > 2.4 × 10^10/L 1, 3
A standard dose should increase the patient's platelet count by approximately 30 × 10^9/L 1, 3
For severe bleeding, an initial dose of 4-8 platelet concentrates or one apheresis pack is recommended 5, 6

Risk of bacterial infection transmission (1 in 12,000) is higher than with other blood components due to storage at 22°C 1, 2
Bacterial screening before release helps reduce this risk 1, 2
Platelets must never be placed in a refrigerator as this damages platelet function 1, 4
The patient's platelet count should be repeated after transfusion to assess response 1, 3

D-negative children and women of childbearing potential should receive D-negative platelets to prevent risk of developing immune anti-D 1, 4
Group O platelets given to non-group O children should be selected to be high-titre negative 1, 4
In trauma settings with massive bleeding, platelet transfusion may need to be incorporated into a broader hemostatic resuscitation strategy 5, 8